A Role for Dopamine-Mediated Learning in the Pathophysiology and Treatment of Parkinson's Disease

Cell Reports

Volumn 2, Issue 6, 2012, Pages 1747-1761

  Beeler, Jeff A ^a   Frank, Michael J ^b   McDaid, John ^a   Alexander, Erin ^a   Turkson, Susie ^a   Sol Bernandez, Maria ^a   McGehee, Daniel S ^a   Zhuang, Xiaoxi ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ADENOSINE A2A RECEPTOR ANTAGONIST; ADENOSINE RECEPTOR BLOCKING AGENT; DOPAMINE; DOPAMINE 2 RECEPTOR; ETICLOPRIDE; MSX 3; SULPIRIDE; THEOPHYLLINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BRAIN CORTEX; BRAIN NERVE CELL; CORPUS STRIATUM; DENERVATION; GLOBUS PALLIDUS; LEARNING; LEARNING DISORDER; MATHEMATICAL MODEL; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RECEPTOR BLOCKING; SIGNAL TRANSDUCTION; SYMPTOM;

ADENOSINE; ANIMALS; BEHAVIOR, ANIMAL; DOPAMINE; LEARNING; MICE; MICE, TRANSGENIC; MOTOR ACTIVITY; PARKINSON DISEASE; RECEPTORS, DOPAMINE D2; SIGNAL TRANSDUCTION;

EID: 84871706502     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2012.11.014     Document Type: Article

References (57)

1. Abbruzzese G., Trompetto C., Marinelli L. The rationale for motor learning in Parkinson's disease. Eur. J. Phys. Rehabil. Med. 2009, 45:209-214.
2. Albin R.L., Young A.B., Penney J.B. The functional anatomy of basal ganglia disorders. Trends Neurosci. 1989, 12:366-375.
3. Alexander G.E., Crutcher M.D., DeLong M.R. Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, " prefrontal" and " limbic" functions. Prog. Brain Res. 1990, 85:119-146.
4. Anderson E., Nutt J. The long-duration response to levodopa: phenomenology, potential mechanisms and clinical implications. Parkinsonism Relat. Disord. 2011, 17:587-592.
5. Archer T., Fredriksson A., Johansson B. Exercise alleviates Parkinsonism: clinical and laboratory evidence. Acta Neurol. Scand. 2011, 123:73-84.
6. Bagetta V., Picconi B., Marinucci S., Sgobio C., Pendolino V., Ghiglieri V., Fusco F.R., Giampà C., Calabresi P. Dopamine-dependent long-term depression is expressed in striatal spiny neurons of both direct and indirect pathways: implications for Parkinson's disease. J. Neurosci. 2011, 31:12513-12522.
7. Balleine B.W., O'Doherty J.P. Human and rodent homologies in action control: corticostriatal determinants of goal-directed and habitual action. Neuropsychopharmacology 2010, 35:48-69.
8. Beeler J.A. Preservation of function in Parkinson's disease: what's learning got to do with it?. Brain Res. 2011, 1423:96-113.
9. Beeler J.A., Cao Z.F.H., Kheirbek M.A., Ding Y., Koranda J., Murakami M., Kang U.J., Zhuang X. Dopamine-dependent motor learning: insight into levodopa's long-duration response. Ann. Neurol. 2010, 67:639-647.
10. Bernheimer H., Birkmayer W., Hornykiewicz O., Jellinger K., Seitelberger F. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J. Neurol. Sci. 1973, 20:415-455.
11. Bódi N., Kéri S., Nagy H., Moustafa A., Myers C.E., Daw N., Dibó G., Takáts A., Bereczki D., Gluck M.A. Reward-learning and the novelty-seeking personality: a between- and within-subjects study of the effects of dopamine agonists on young Parkinson's patients. Brain 2009, 132:2385-2395.
12. Calabresi P., Maj R., Pisani A., Mercuri N.B., Bernardi G. Long-term synaptic depression in the striatum: physiological and pharmacological characterization. J. Neurosci. 1992, 12:4224-4233.
13. Calabresi P., Pisani A., Mercuri N.B., Bernardi G. Long-term Potentiation in the Striatum is Unmasked by Removing the Voltage-dependent Magnesium Block of NMDA Receptor Channels. Eur. J. Neurosci. 1992, 4:929-935.
14. Calabresi P., Saiardi A., Pisani A., Baik J.H., Centonze D., Mercuri N.B., Bernardi G., Borrelli E. Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors. J. Neurosci. 1997, 17:4536-4544.
15. Calabresi P., Picconi B., Tozzi A., Di Filippo M. Dopamine-mediated regulation of corticostriatal synaptic plasticity. Trends Neurosci. 2007, 30:211-219.
16. Costa R.M., Cohen D., Nicolelis M.A.L. Differential corticostriatal plasticity during fast and slow motor skill learning in mice. Curr. Biol. 2004, 14:1124-1134.
17. Doyon J., Bellec P., Amsel R., Penhune V., Monchi O., Carrier J., Lehéricy S., Benali H. Contributions of the basal ganglia and functionally related brain structures to motor learning. Behav. Brain Res. 2009, 199:61-75.
18. El Yacoubi M., Ledent C., Ménard J.F., Parmentier M., Costentin J., Vaugeois J.M. The stimulant effects of caffeine on locomotor behaviour in mice are mediated through its blockade of adenosine A(2A) receptors. Br. J. Pharmacol. 2000, 129:1465-1473.
19. Frank M.J. Dynamic dopamine modulation in the basal ganglia: a neurocomputational account of cognitive deficits in medicated and nonmedicated Parkinsonism. J. Cogn. Neurosci. 2005, 17:51-72.
20. Frank M.J., Seeberger L.C., O'reilly R.C. By carrot or by stick: cognitive reinforcement learning in parkinsonism. Science 2004, 306:1940-1943.
21. Gerdeman G.L., Ronesi J., Lovinger D.M. Postsynaptic endocannabinoid release is critical to long-term depression in the striatum. Nat. Neurosci. 2002, 5:446-451.
22. Gertler T.S., Chan C.S., Surmeier D.J. Dichotomous anatomical properties of adult striatal medium spiny neurons. J. Neurosci. 2008, 28:10814-10824.
23. Graybiel A.M. Habits, rituals, and the evaluative brain. Annu. Rev. Neurosci. 2008, 31:359-387.
24. Hikida T., Kimura K., Wada N., Funabiki K., Nakanishi S. Distinct roles of synaptic transmission in direct and indirect striatal pathways to reward and aversive behavior. Neuron 2010, 66:896-907.
25. Hornykiewicz O. Chemical neuroanatomy of the basal ganglia-normal and in Parkinson's disease. J. Chem. Neuroanat. 2001, 22:3-12.
26. Hsu C.W., Wang C.S., Chiu T.H. Caffeine and a selective adenosine A2A receptor antagonist induce sensitization and cross-sensitization behavior associated with increased striatal dopamine in mice. J. Biomed. Sci. 2010, 17:4.
27. Jin X., Costa R.M. Start/stop signals emerge in nigrostriatal circuits during sequence learning. Nature 2010, 466:457-462.
28. Kelsey J.E., Langelier N.A., Oriel B.S., Reedy C. The effects of systemic, intrastriatal, and intrapallidal injections of caffeine and systemic injections of A2A and A1 antagonists on forepaw stepping in the unilateral 6-OHDA-lesioned rat. Psychopharmacology (Berl.) 2009, 201:529-539.
29. Keus S.H.J., Munneke M., Nijkrake M.J., Kwakkel G., Bloem B.R. Physical therapy in Parkinson's disease: evolution and future challenges. Mov. Disord. 2009, 24:1-14.
30. Kostic V.S., Svetel M., Sternic N., Dragasevic N., Przedborski S. Theophylline increases " on" time in advanced parkinsonian patients. Neurology 1999, 52:1916.
31. Kravitz A.V., Freeze B.S., Parker P.R.L., Kay K., Thwin M.T., Deisseroth K., Kreitzer A.C. Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry. Nature 2010, 466:622-626.
32. Kreitzer A.C., Malenka R.C. Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models. Nature 2007, 445:643-647.
33. Kreitzer A.C., Malenka R.C. Striatal plasticity and basal ganglia circuit function. Neuron 2008, 60:543-554.
34. Kulisevsky J., Barbanoj M., Gironell A., Antonijoan R., Casas M., Pascual-Sedano B. A double-blind crossover, placebo-controlled study of the adenosine A2A antagonist theophylline in Parkinson's disease. Clin. Neuropharmacol. 2002, 25:25-31.
35. Lovinger D.M. Neurotransmitter roles in synaptic modulation, plasticity and learning in the dorsal striatum. Neuropharmacology 2010, 58:951-961.
36. Mallet N., Le Moine C., Charpier S., Gonon F. Feedforward inhibition of projection neurons by fast-spiking GABA interneurons in the rat striatum in vivo. J. Neurosci. 2005, 25:3857-3869.
37. Mally J., Stone T.W. Potential role of adenosine antagonist therapy in pathological tremor disorders. Pharmacol. Ther. 1996, 72:243-250.
38. Mink J.W. The basal ganglia: focused selection and inhibition of competing motor programs. Prog. Neurobiol. 1996, 50:381-425.
39. Miyachi S., Hikosaka O., Lu X. Differential activation of monkey striatal neurons in the early and late stages of procedural learning. Exp. Brain Res. 2002, 146:122-126.
40. Muenter M., Tyce G. L-dopa therapy of Parkinson's disease: plasma L-dopa concentration, therapeutic response, and side effects. Mayo Clin. Proc. 1971, 46:231-239.
41. Nieuwboer A., Rochester L., Müncks L., Swinnen S.P. Motor learning in Parkinson's disease: limitations and potential for rehabilitation. Parkinsonism Relat. Disord. 2009, 15(Suppl 3):S53-S58.
42. Nutt J., Carter J., Van Houten L. Short- and long-duration responses to levodopa during the first year of levodopa therapy. Ann. Neurol. 1997, 42:349-355.
43. Palminteri S., Lebreton M., Worbe Y., Grabli D., Hartmann A., Pessiglione M. Pharmacological modulation of subliminal learning in Parkinson's and Tourette's syndromes. Proc. Natl. Acad. Sci. USA 2009, 106:19179-19184.
44. Peterson J.D., Goldberg J.A., Surmeier D.J. Adenosine A2a receptor antagonists attenuate striatal adaptations following dopamine depletion. Neurobiol. Dis. 2012, 45:409-416.
45. Picconi B., Centonze D., Håkansson K., Bernardi G., Greengard P., Fisone G., Cenci M.A., Calabresi P. Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia. Nat. Neurosci. 2003, 6:501-506.
46. Poldrack R.A., Sabb F.W., Foerde K., Tom S.M., Asarnow R.F., Bookheimer S.Y., Knowlton B.J. The neural correlates of motor skill automaticity. J. Neurosci. 2005, 25:5356-5364.
47. Puttemans V., Wenderoth N., Swinnen S.P. Changes in brain activation during the acquisition of a multifrequency bimanual coordination task: from the cognitive stage to advanced levels of automaticity. J. Neurosci. 2005, 25:4270-4278.
48. Quiroz C., Luján R., Uchigashima M., Simoes A.P., Lerner T.N., Borycz J., Kachroo A., Canas P.M., Orru M., Schwarzschild M.A., et al. Key modulatory role of presynaptic adenosine A2A receptors in cortical neurotransmission to the striatal direct pathway. ScientificWorldJournal 2009, 9:1321-1344.
49. Schiffmann S.N., Dassesse D., d'Alcantara P., Ledent C., Swillens S., Zoli M. A2A receptor and striatal cellular functions: regulation of gene expression, currents, and synaptic transmission. Neurology 2003, 61(11, Suppl 6):S24-S29.
50. Shen W., Flajolet M., Greengard P., Surmeier D.J. Dichotomous dopaminergic control of striatal synaptic plasticity. Science 2008, 321:848-851.
51. Surmeier D.J., Plotkin J., Shen W. Dopamine and synaptic plasticity in dorsal striatal circuits controlling action selection. Curr. Opin. Neurobiol. 2009, 19:621-628.
52. Tang C., Pawlak A.P., Prokopenko V., West M.O. Changes in activity of the striatum during formation of a motor habit. Eur. J. Neurosci. 2007, 25:1212-1227.
53. Tozzi A., Tscherter A., Belcastro V., Tantucci M., Costa C., Picconi B., Centonze D., Calabresi P., Borsini F. Interaction of A2A adenosine and D2 dopamine receptors modulates corticostriatal glutamatergic transmission. Neuropharmacology 2007, 53:783-789.
54. Wickens J.R. Synaptic plasticity in the basal ganglia. Behav. Brain Res. 2009, 199:119-128.
55. Wiecki T.V., Frank M.J. Neurocomputational models of motor and cognitive deficits in Parkinson's disease. Prog. Brain Res. 2010, 183:275-297.
56. Wiecki T.V., Riedinger K., von Ameln-Mayerhofer A., Schmidt W.J., Frank M.J. A neurocomputational account of catalepsy sensitization induced by D2 receptor blockade in rats: context dependency, extinction, and renewal. Psychopharmacology (Berl.) 2009, 204:265-277.
57. Yin H.H., Mulcare S.P., Hilário M.R.F., Clouse E., Holloway T., Davis M.I., Hansson A.C., Lovinger D.M., Costa R.M. Dynamic reorganization of striatal circuits during the acquisition and consolidation of a skill. Nat. Neurosci. 2009, 12:333-341.